Digoxin and Heart Failure: Are We Clear Yet?
The Digoxin Investigation Group trial has multiple flaws in the trial design for the findings to be universally applicable. Digoxin in low serum concentrations (0.5–0.9 ng/mL) has been shown to decrease mortality in heart failure patients. Multiple trials in different patient populations also show b...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Compuscript Ltd
2017-04-01
|
| Col·lecció: | Cardiovascular Innovations and Applications |
| Accés en línia: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2016.0044 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|